Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.5 USD | +3.06% |
|
+5.16% | +41.55% |
06-24 | ITeos Therapeutics, Inc.(NasdaqGM:ITOS) added to S&P Biotechnology Select Industry Index | CI |
06-17 | GSK: Phase III study with iTeos begins | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.55% | 560M | |
+16.13% | 122B | |
+19.65% | 115B | |
+21.22% | 26.64B | |
-23.84% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-19.28% | 15.49B | |
+63.81% | 14.83B | |
+1.94% | 13.67B |
- Stock Market
- Equities
- ITOS Stock
- News iTeos Therapeutics, Inc.
- iTeos Therapeutics : Wedbush Adjusts Price Target on ITeos Therapeutics to $46 From $45, Keeps Outperform Rating